BOLERO3_2: BOLERO3, figure 2

BOLERO3_2R Documentation

BOLERO3, figure 2

Description

Kaplan-Meier digitized data from BOLERO3, figure 2 (PMID 24742739). A reported sample size of 569 for a primary endpoint of PFS in breast cancer.

Usage

BOLERO3_2

Format

A data frame of 569 observations and 3 variables:

time event time (in weeks)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (eve_exe, placebo)

Source

André F, O’Regan R, Ozguroglu M, et al. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Oncol 2014; 15: 580–91.

Examples

summary(BOLERO3_2)

kmplot(BOLERO3_2)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.